Review



pad4 rabbit anti mouse primary antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Proteintech pad4 rabbit anti mouse primary antibody
    Figure 5. ONL PR counts and retinal <t>PAD4</t> immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.
    Pad4 Rabbit Anti Mouse Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 87 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad4+rabbit+anti+mouse+primary+antibody/pm38396985-354-0-5?v=Proteintech
    Average 95 stars, based on 87 article reviews
    pad4 rabbit anti mouse primary antibody - by Bioz Stars, 2026-07
    95/100 stars

    Images

    1) Product Images from "Loss of 15-Lipoxygenase in Retinodegenerative RCS Rats."

    Article Title: Loss of 15-Lipoxygenase in Retinodegenerative RCS Rats.

    Journal: International journal of molecular sciences

    doi: 10.3390/ijms25042309

    Figure 5. ONL PR counts and retinal PAD4 immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.
    Figure Legend Snippet: Figure 5. ONL PR counts and retinal PAD4 immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.

    Techniques Used: Immunofluorescence, Staining, Preserving, Fluorescence

    Figure 9. Effects on rd10 mice treated with NAP1051. rd10 mice treated with NAP1051 from p15 to p26 showed ONL preservation on OCT (arrows) and H&E on p26 (A). NAP1051 was able to preserve ONL thickness (B) and PR counts (C). OCT-FAF showed NAP1051 reduced hyperpigmentation on p26 (D,E). Correlations between the ONL PR counts and FAF hyperpigmentation were evaluated and demonstrated a negative linear correlation (R2 = 0.9) where fewer hyperpigmentation spots were correlated to increased ONL PR nuclei (F). Retinal PAD4 immunofluorescence staining was reduced for animals treated with 37.5 mg/kg/BID (G) corresponding with reduced retinal H3Cit, but not to a statistically significant level (H). The oxidative stress marker malondialdehyde (MDA) was statisti- cally significantly reduced at the 37.5 mg/kg/BID dosage (I). Data represented as median ± 95% CI, * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s correction. The number of PRs in the ONL and hyperpigmentation spots seen in FAF were enumerated using ImageJ/FIJI (ver 2.3.0).
    Figure Legend Snippet: Figure 9. Effects on rd10 mice treated with NAP1051. rd10 mice treated with NAP1051 from p15 to p26 showed ONL preservation on OCT (arrows) and H&E on p26 (A). NAP1051 was able to preserve ONL thickness (B) and PR counts (C). OCT-FAF showed NAP1051 reduced hyperpigmentation on p26 (D,E). Correlations between the ONL PR counts and FAF hyperpigmentation were evaluated and demonstrated a negative linear correlation (R2 = 0.9) where fewer hyperpigmentation spots were correlated to increased ONL PR nuclei (F). Retinal PAD4 immunofluorescence staining was reduced for animals treated with 37.5 mg/kg/BID (G) corresponding with reduced retinal H3Cit, but not to a statistically significant level (H). The oxidative stress marker malondialdehyde (MDA) was statisti- cally significantly reduced at the 37.5 mg/kg/BID dosage (I). Data represented as median ± 95% CI, * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s correction. The number of PRs in the ONL and hyperpigmentation spots seen in FAF were enumerated using ImageJ/FIJI (ver 2.3.0).

    Techniques Used: Preserving, Immunofluorescence, Staining, Marker



    Similar Products

    pad4 rabbit anti mouse primary antibody  (Proteintech)
    95
    Proteintech pad4 rabbit anti mouse primary antibody
    Figure 5. ONL PR counts and retinal <t>PAD4</t> immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.
    Pad4 Rabbit Anti Mouse Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pad4+rabbit+anti+mouse+primary+antibody/pm38396985-354-0-5?v=Proteintech
    Average 95 stars, based on 1 article reviews
    pad4 rabbit anti mouse primary antibody - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Figure 5. ONL PR counts and retinal PAD4 immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.

    Journal: International journal of molecular sciences

    Article Title: Loss of 15-Lipoxygenase in Retinodegenerative RCS Rats.

    doi: 10.3390/ijms25042309

    Figure Lengend Snippet: Figure 5. ONL PR counts and retinal PAD4 immunofluorescence staining. IVT NAP1051 adminis- tration promotes PR preservation in a dosage-dependent manner (A), which was correlated with PR counts (B). Adjacent histological sections were stained with anti-PAD4 (red) antibodies and DAPI (blue) (C), which showed reduced retinal PAD4 fluorescence intensity (D). Data represented as median ± 95% CI, * p < 0.05, Kruskal–Wallis with Dunn’s correction.

    Article Snippet: PAD4 rabbit anti-mouse primary antibody (Proteintech, Sankt Leon-Rot, Germany, Cat. # 17373-1-AP), H3Cit polyclonal rabbit anti-mouse (Abcam, Cambridge, UK, Cat. # ab5103), and MDA polyclonal rabbit anti-mouse (Abcam, Cambridge, UK, Cat. # ab27642) primary antibodies were diluted in blocking buffer and added to each retina and incubated overnight at 4 ◦C.

    Techniques: Immunofluorescence, Staining, Preserving, Fluorescence

    Figure 9. Effects on rd10 mice treated with NAP1051. rd10 mice treated with NAP1051 from p15 to p26 showed ONL preservation on OCT (arrows) and H&E on p26 (A). NAP1051 was able to preserve ONL thickness (B) and PR counts (C). OCT-FAF showed NAP1051 reduced hyperpigmentation on p26 (D,E). Correlations between the ONL PR counts and FAF hyperpigmentation were evaluated and demonstrated a negative linear correlation (R2 = 0.9) where fewer hyperpigmentation spots were correlated to increased ONL PR nuclei (F). Retinal PAD4 immunofluorescence staining was reduced for animals treated with 37.5 mg/kg/BID (G) corresponding with reduced retinal H3Cit, but not to a statistically significant level (H). The oxidative stress marker malondialdehyde (MDA) was statisti- cally significantly reduced at the 37.5 mg/kg/BID dosage (I). Data represented as median ± 95% CI, * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s correction. The number of PRs in the ONL and hyperpigmentation spots seen in FAF were enumerated using ImageJ/FIJI (ver 2.3.0).

    Journal: International journal of molecular sciences

    Article Title: Loss of 15-Lipoxygenase in Retinodegenerative RCS Rats.

    doi: 10.3390/ijms25042309

    Figure Lengend Snippet: Figure 9. Effects on rd10 mice treated with NAP1051. rd10 mice treated with NAP1051 from p15 to p26 showed ONL preservation on OCT (arrows) and H&E on p26 (A). NAP1051 was able to preserve ONL thickness (B) and PR counts (C). OCT-FAF showed NAP1051 reduced hyperpigmentation on p26 (D,E). Correlations between the ONL PR counts and FAF hyperpigmentation were evaluated and demonstrated a negative linear correlation (R2 = 0.9) where fewer hyperpigmentation spots were correlated to increased ONL PR nuclei (F). Retinal PAD4 immunofluorescence staining was reduced for animals treated with 37.5 mg/kg/BID (G) corresponding with reduced retinal H3Cit, but not to a statistically significant level (H). The oxidative stress marker malondialdehyde (MDA) was statisti- cally significantly reduced at the 37.5 mg/kg/BID dosage (I). Data represented as median ± 95% CI, * p < 0.05, ** p < 0.01, Kruskal–Wallis test with Dunn’s correction. The number of PRs in the ONL and hyperpigmentation spots seen in FAF were enumerated using ImageJ/FIJI (ver 2.3.0).

    Article Snippet: PAD4 rabbit anti-mouse primary antibody (Proteintech, Sankt Leon-Rot, Germany, Cat. # 17373-1-AP), H3Cit polyclonal rabbit anti-mouse (Abcam, Cambridge, UK, Cat. # ab5103), and MDA polyclonal rabbit anti-mouse (Abcam, Cambridge, UK, Cat. # ab27642) primary antibodies were diluted in blocking buffer and added to each retina and incubated overnight at 4 ◦C.

    Techniques: Preserving, Immunofluorescence, Staining, Marker